Segmentation by types classifies supplements according to their core ingredient families, elucidating how formulation choices drive market dynamics. Natural extracts—such as Ginkgo biloba, Bacopa monnieri, and Rhodiola—represent the largest share, approximately 45%, due to consumer preference for botanically derived solutions and extensive safety data. Synthetic nootropics, including racetams and modafinil analogues, account for 30% of the market, appealing to users seeking rapid, quantifiable cognitive gains despite stricter regulatory scrutiny. Vitamin and mineral complexes, featuring B‑vitamins, magnesium, and zinc, contribute 15%, serving as foundational support for neurochemical pathways. Amino‑acid derivatives, like L‑theanine and acetyl‑L‑carnitine, comprise the remaining 10%, often combined with other categories to enhance synergistic effects. By mapping these sub‑types, analysts can assess formulation trends, supply‑chain dependencies, and potential growth niches within the broader Brain Function Supplement market.